Registry of Pediatric Patients Diagnosed With Crohn's Disease in Belgium

Description of Disease Course, Disease Fenotype, Medication, Safety, Analysis for Possible Associations Clinical Trial

— Belcro  

Official title:

Belgian Registry of Pediatric Crohn's Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01241058
• Other study ID #: Bespghan
• Status: Completed
• Phase: N/A
• First received: November 15, 2010
• Last updated: January 17, 2016
• Start date: May 2008
• Est. completion date: April 2015

Study information

• Verified date: January 2016
• Source: Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition
• Contact: n/a
• Is FDA regulated: No
• Health authority: Belgium: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

A registry of pediatric patients (under 18 yrs of age) diagnosed with Crohn's disease was created in Belgium. Over a 2 year period 257 patients are included. These patients will be follow up prospectively during 5 years. Demographic data, family history, disease presentation and disease course including medication are registered in CRF's.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 257
• Est. completion date: April 2015
• Est. primary completion date: April 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 1 Year to 18 Years

Eligibility

Inclusion Criteria:

1-18 yrs old belgian Crohn s disease informed consent

Exclusion Criteria:

no informed consent

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Crohn Disease
• Description of Disease Course, Disease Fenotype, Medication, Safety, Analysis for Possible Associations
• Disease Progression

Locations

Country	Name	City	State
Belgium	Bespghan	Leuven	Brabant

Sponsors (1)

Lead Sponsor	Collaborator
Gigi Veereman

Country where clinical trial is conducted

Belgium, 

References & Publications (4)

Alliet P, Desimpelaere J, Hauser B, Janssens E, Khamis J, Lewin M, De Greef E, Smets F, Paquot I, Veereman G, Souverijns G; Belgian IBD working group of BeSPGHAN. MR enterography in children with Crohn disease: results from the Belgian pediatric Crohn reg — View Citation

De Greef E, Mahachie John JM, Hoffman I, Smets F, Van Biervliet S, Scaillon M, Hauser B, Paquot I, Alliet P, Arts W, Dewit O, Peeters H, Baert F, D'Haens G, Rahier JF, Etienne I, Bauraind O, Van Gossum A, Vermeire S, Fontaine F, Muls V, Louis E, Van de Mi — View Citation

De Greef E, Maus B, Smets F, Van Biervliet S, John JM, Van Steen K, Veereman G; IBD working group of the Belgian Society of Pediatric Gastroenterology, Hepatology and Nutrition (BeSPGHAN); Belgian IBD Research and Development (BIRD). Diagnosing and treati — View Citation

Van Biervliet S, Smets F, Hofmann I, Degreef E, Hauser B, Bontems P, Vande Velde S, Arts W, Paquot I, Alliet P, Bossuyt P, Louis E, Baert F, Bauraind O, Rahier JF, Veereman G. The course of anaemia in children and adolescents with Crohn's disease included — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	disease course	describe patient characteristics, disease fenotype and course	5 years	No